Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GALP ELISA Kit (AC2789)
Cat.#: ASET-1378
Specifications
Description Human GALP ELISA Kit allows for the in vitro quantitative determination of human GALP concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1525 Human beta Catenin ELISA Kit (AC2936) Quantitative inquiry ASET-1450 Human KCC2 ELISA Kit (AC2861) Quantitative inquiry ASET-1171 Human SYT6 ELISA Kit (AC2582) Quantitative inquiry ASET-2134 Human Myotrophin ELISA Kit (AC3545) Quantitative inquiry ASET-1371 Human PNMT ELISA Kit (AC2782) Quantitative inquiry ASET-1020 Human CACNA1A ELISA Kit (AC2431) Quantitative inquiry ASET-2477 Porcine Slit2 ELISA Kit (AC3888) Quantitative inquiry ASET-1480 Human GDF6 ELISA Kit (AC2891) Quantitative inquiry ASET-1237 Human NRXN3 ELISA Kit (AC2648) Quantitative inquiry ASET-1859 Human G-Protein Coupled Receptor 30 ELISA Kit (AC3270) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket